ASX-listed imaging technology developer 4DMedical Limited has signed a teaming agreement with Koninklijke Philips, a leading global healthcare company, to commercialise 4D Medical’s XV Technology within the US Department of Veterans Affairs.
The partnership marks a major milestone in 4D Medical’s commercialisation strategy, particularly within the VA.
Philips and 4D Medical will work together to support the massive need to scale non-invasive lung screening in support of the PACT Act, which extended eligibility for benefits to an additional 4.5 million veterans in the United States.
Under the teaming agreement, the two companies will collaborate to advance solutions to evaluate Veterans for deployment-related respiratory diseases as part of a broader lung screening initiative.
Philips and 4DMedical will offer 4D lung imaging as a critical solution for Veterans exposed to burn pits and other airborne hazards on deployment.
They will collaborate to develop solutions for toxic exposure and lung screening using 4D Medical software and Philips fluoroscopy and CT systems.
Philips has long-established partnerships with both the VA and the US Department of Defense going back 45 years, deploying 35 per cent of the critical care information systems across the VA. The company has also equipped 50 per cent of VA hospitals with its imaging solutions.
The partnership offers 4DMedical access to a team of industry experts with unparalleled relationships in global healthcare and unprecedented opportunities to accelerate its go-to-market activities, particularly in the VA.
“Starting 2024 by formalising this teaming agreement with Philips is an exceptional way to commence the year and an incredible opportunity for 4D to accelerate our mission,” said Andreas Fouras, MD/CEO and founder of 4DMedical.
“The speed of executing the teaming agreement, so rapidly after signing the MoU, is testament to the leadership commitment by the team at Philips North America, where their service to Veterans has been palpable throughout. The size and reach of Philips will dramatically accelerate the scaling of our offering within the VA.”
